Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-13-001370
Filing Date
2013-02-11
Accepted
2013-02-11 17:08:28
Documents
11
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q biota_10q-123112.htm 10-Q 1037842
2 EXHIBIT 3.1 ex3-1.htm EX-3.1 50625
3 EXHIBIT 3.2 ex3-2.htm EX-3.2 116218
4 EXHIBIT 31.1 ex31-1.htm EX-31.1 18933
5 EXHIBIT 32.1 ex32-1.htm EX-32.1 9169
  Complete submission text file 0001437749-13-001370.txt   6364512

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS bota-20121231.xml EX-101.INS 1103253
7 EXHIBIT 101.SCH bota-20121231.xsd EX-101.SCH 36517
8 EXHIBIT 101.CAL bota-20121231_cal.xml EX-101.CAL 23771
9 EXHIBIT 101.DEF bota-20121231_def.xml EX-101.DEF 231367
10 EXHIBIT 101.LAB bota-20121231_lab.xml EX-101.LAB 304191
11 EXHIBIT 101.PRE bota-20121231_pre.xml EX-101.PRE 231391
Mailing Address 12270 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12270 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
Biota Pharmaceuticals, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 13592912
SIC: 2836 Biological Products, (No Diagnostic Substances)